Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Arihiro Kiyosue
Observed names:
A Kiyosue,
A. Kiyosue,
ARIHIRO KIYOSUE,
Kiyosue, Arihiro
Institutions:
University of Tokyo Hospital,
The University of Tokyo
Observed institutions:
Amgen (United States),
Jichi Medical University,
Keio University,
University of Oxford,
Keio University Hospital,
University of Tokyo Hospital,
MRC Population Health Research Unit,
The University of Tokyo
show all 8
ORCID:
0000-0003-3201-7846
Observed ORCID:
0000-0003-3201-7846
OpenAlex ID:
A5048971859
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
2019
·
Hiddo J L Heerspink
, Hans-Henrik Parving
, et al.
·
The Lancet
·
687
PDF
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial
2019
·
Bernard Zinman
, Vanita R. Aroda
, et al.
·
Diabetes Care
·
342
Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial
2020
·
Yuichiro Yamada
, Hideki Katagiri
, et al.
·
The Lancet Diabetes & Endocrinology
·
257
PDF
Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial
2020
·
Daisuke Yabe
, Jiro Nakamura
, et al.
·
The Lancet Diabetes & Endocrinology
·
234
Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial
2023
·
Hiddo J L Heerspink
, Arihiro Kiyosue
, et al.
·
The Lancet
·
175
PDF
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial
2023
·
PK Judge
, N Staplin
, et al.
·
The Lancet Diabetes & Endocrinology
·
155
PDF
Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double‐blind, placebo‐controlled trial
2012
·
K. Kaku
, S. Inoue
, et al.
·
Diabetes Obesity and Metabolism
·
150
Safety and efficacy of once‐weekly semaglutide vs additional oral antidiabetic drugs in Japanese people with inadequately controlled type 2 diabetes: A randomized trial
2018
·
Kohei Kaku
, Yuichiro Yamada
, et al.
·
Diabetes Obesity and Metabolism
·
140
PDF
Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial
2021
·
Hiddo J L Heerspink
, C David Sjöström
, et al.
·
European Heart Journal
·
137
PDF
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial
2023
·
N Staplin
, R Haynes
, et al.
·
The Lancet Diabetes & Endocrinology
·
134
PDF
A Phase 3 Study of Evolocumab (AMG 145) in Statin-Treated Japanese Patients at High Cardiovascular Risk
2015
·
Arihiro Kiyosue
, Narimon Honarpour
, et al.
·
The American Journal of Cardiology
·
120
PDF
Efficacy and safety of dapagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise
2014
·
K. Kaku
, A. Kiyosue
, et al.
·
Diabetes Obesity and Metabolism
·
117
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
2021
·
Hiddo J.L. Heerspink
, David Cherney
, et al.
·
Kidney International
·
103
PDF
Diagnosing Heart Failure from Chest X-Ray Images Using Deep Learning
2020
·
Takuya Matsumoto
, Satoshi Kodera
, et al.
·
International Heart Journal
·
78
PDF
Dose‐ranging study with the glucokinase activator AZD1656 as monotherapy in Japanese patients with type 2 diabetes mellitus
2013
·
A. Kiyosue
, N. Hayashi
, et al.
·
Diabetes Obesity and Metabolism
·
72
Dapagliflozin as Monotherapy or Combination Therapy in Japanese Patients with Type 2 Diabetes: an Open-Label Study
2014
·
Kohei Kaku
, Hiroshi Maegawa
, et al.
·
Diabetes Therapy
·
64
PDF
Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy
2020
·
Kieran F. Docherty
, Pardeep S. Jhund
, et al.
·
Diabetes Care
·
46
Prognostic implication of macrocytosis on adverse outcomes after coronary intervention
2011
·
Masahiro Myojo
, Hiroshi Iwata
, et al.
·
Atherosclerosis
·
45
Cost effectiveness of transcatheter aortic valve implantation in patients with aortic stenosis in Japan
2017
·
Satoshi Kodera
, Arihiro Kiyosue
, et al.
·
Journal of Cardiology
·
43
PDF
Comparative effects of topiroxostat and febuxostat on arterial properties in hypertensive patients with hyperuricemia
2021
·
Kazuomi Kario
, Masafumi Nishizawa
, et al.
·
Journal of Clinical Hypertension
·
42
PDF
Involvement of P2Y12 receptor in vascular smooth muscle inflammatory changes via MCP-1 upregulation and monocyte adhesion
2015
·
Hiroshi Satonaka
, Daisuke Nagata
, et al.
·
American Journal of Physiology-Heart and Circulatory Physiology
·
42
Hyperuricemia predicts increased cardiovascular events in patients with chronic coronary syndrome after percutaneous coronary intervention: A nationwide cohort study from Japan
2023
·
Naoyuki Akashi
, Masanari Kuwabara
, et al.
·
Frontiers in Cardiovascular Medicine
·
40
Plasma Cystatin C Concentration Reflects the Severity of Coronary Artery Disease in Patients Without Chronic Kidney Disease
2010
·
Arihiro Kiyosue
, Yasunobu Hirata
, et al.
·
Circulation Journal
·
38
PDF
Relationship Between Renal Dysfunction and Severity of Coronary Artery Disease in Japanese Patients
2010
·
Arihiro Kiyosue
, Yasunobu Hirata
, et al.
·
Circulation Journal
·
37
PDF
A new constitutively active mutant of AMP-activated protein kinase inhibits anoxia-induced apoptosis of vascular endothelial cell
2009
·
Daisuke Nagata
, Arihiro Kiyosue
, et al.
·
Hypertension Research
·
35
PDF
Show more works
View as search
Works count:
121
Citation count:
4,138
H-index:
29
I10-index:
57
Year
Topic
Type